244 related articles for article (PubMed ID: 27448625)
1. Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines.
Harris RC; Sumner T; Knight GM; White RG
Hum Vaccin Immunother; 2016 Nov; 12(11):2813-2832. PubMed ID: 27448625
[TBL] [Abstract][Full Text] [Related]
2. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India.
Shrestha S; Chatterjee S; Rao KD; Dowdy DW
J R Soc Interface; 2016 Mar; 13(116):. PubMed ID: 27009179
[TBL] [Abstract][Full Text] [Related]
3. Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.
Knight GM; Griffiths UK; Sumner T; Laurence YV; Gheorghe A; Vassall A; Glaziou P; White RG
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15520-5. PubMed ID: 25288770
[TBL] [Abstract][Full Text] [Related]
4. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy A; Clark RA; Quaife M; Weerasuriya CK; Mukandavire C; Bakker R; Deol AK; Malhotra S; Gebreselassie N; Zignol M; Sim SY; Hutubessy RCW; Baena IG; Nishikiori N; Jit M; White RG; Menzies NA
PLoS Med; 2023 Jan; 20(1):e1004155. PubMed ID: 36693081
[TBL] [Abstract][Full Text] [Related]
5. Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine.
Fu H; Lewnard JA; Frost I; Laxminarayan R; Arinaminpathy N
Nat Commun; 2021 Jan; 12(1):424. PubMed ID: 33462224
[TBL] [Abstract][Full Text] [Related]
6. Potential impact of tuberculosis vaccines in China, South Africa, and India.
Harris RC; Sumner T; Knight GM; Zhang H; White RG
Sci Transl Med; 2020 Oct; 12(564):. PubMed ID: 33028708
[TBL] [Abstract][Full Text] [Related]
7. Update on research and development pipeline: tuberculosis vaccines.
Beresford B; Sadoff JC
Clin Infect Dis; 2010 May; 50 Suppl 3():S178-83. PubMed ID: 20397946
[TBL] [Abstract][Full Text] [Related]
8. Potential public health impact of new tuberculosis vaccines.
Ziv E; Daley CL; Blower S
Emerg Infect Dis; 2004 Sep; 10(9):1529-35. PubMed ID: 15498152
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.
Tseng CL; Oxlade O; Menzies D; Aspler A; Schwartzman K
BMC Public Health; 2011 Jan; 11():55. PubMed ID: 21269503
[TBL] [Abstract][Full Text] [Related]
10. From AIDS to TB vaccines--A career in infectious diseases and translational vaccinology.
McShane H
Hum Vaccin Immunother; 2016; 12(1):5-7. PubMed ID: 26558654
[No Abstract] [Full Text] [Related]
11. Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.
Penn-Nicholson A; Geldenhuys H; Burny W; van der Most R; Day CL; Jongert E; Moris P; Hatherill M; Ofori-Anyinam O; Hanekom W; ; Bollaerts A; Demoitie MA; Kany Luabeya AK; De Ruymaeker E; Tameris M; Lapierre D; Scriba TJ
Vaccine; 2015 Jul; 33(32):4025-34. PubMed ID: 26072017
[TBL] [Abstract][Full Text] [Related]
12. The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.
Weerasuriya CK; Harris RC; McQuaid CF; Bozzani F; Ruan Y; Li R; Li T; Rade K; Rao R; Ginsberg AM; Gomez GB; White RG
BMC Med; 2021 Feb; 19(1):60. PubMed ID: 33632218
[TBL] [Abstract][Full Text] [Related]
13. [Duties of TB patients or suspected patients and their close relations].
Zielonka TM
Wiad Lek; 2012; 65(1):3-9. PubMed ID: 22827109
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis vaccines and prevention of infection.
Hawn TR; Day TA; Scriba TJ; Hatherill M; Hanekom WA; Evans TG; Churchyard GJ; Kublin JG; Bekker LG; Self SG
Microbiol Mol Biol Rev; 2014 Dec; 78(4):650-71. PubMed ID: 25428938
[TBL] [Abstract][Full Text] [Related]
15. Human biomarkers: can they help us to develop a new tuberculosis vaccine?
Fletcher HA; Dockrell HM
Future Microbiol; 2016 Jun; 11():781-7. PubMed ID: 27203133
[TBL] [Abstract][Full Text] [Related]
16. Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.
Harris RC; Sumner T; Knight GM; Evans T; Cardenas V; Chen C; White RG
Lancet Glob Health; 2019 Feb; 7(2):e209-e218. PubMed ID: 30630775
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis vaccine: time to look into future.
Chawla S; Garg D; Jain RB; Khanna P; Choudhary S; Sahoo S; Singh I
Hum Vaccin Immunother; 2014; 10(2):420-2. PubMed ID: 24231233
[TBL] [Abstract][Full Text] [Related]
18. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
[TBL] [Abstract][Full Text] [Related]
19. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
[TBL] [Abstract][Full Text] [Related]
20. The current state of tuberculosis vaccines.
Hokey DA; Ginsberg A
Hum Vaccin Immunother; 2013 Oct; 9(10):2142-6. PubMed ID: 23792698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
